There are currently 20 active clinical trials seeking participants for Hepatitis C research studies. The states with the highest number of trials for Autism participants are California, Texas, New York and Florida.
Evaluation of Patients With Liver Disease
NCT00001971
Recruiting
The proposed study aims to evaluate, investigate, and follow-up patients suffering from acute and chronic liver disease. The study will focus on understanding diseases affecting the liver. Patients participating in the study will first undergo a routine check-up as an outpatient. They will be asked to provide blood and urine samples for laboratory testing and will undergo an ultrasound of the liver. Ultrasound examinations use sound waves to determine the size and texture of the liver. After th... Read More
Gender:
All
Ages:
2 years and above
Trial Updated:
04/13/2024
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland
Conditions: Liver Disease, Hepatitis D, Hepatitis C, Hepatitis B
Register for Updates
Feasibility and Acceptability of HCV Treatment in Pregnancy
NCT06367465
Recruiting
Pregnant adults over the age of 18 who are seen in the Washington University obstetrics and gynecology, maternal fetal medicine or infectious diseases clinic or admitted to BJH with hepatitis C virus infection who have a history of past or current drug use Participant Duration: Approximately 1 year. Aims: Aim 1 - Evaluate adherence and treatment completion rates when glecaprevir-pibrentasvir is started during pregnancy for women who use drugs. Aim 2 - Evaluate patient experience with hepatit... Read More
Gender:
Female
Ages:
18 years and above
Trial Updated:
04/11/2024
Locations: Barnes Jewish Hospital, Saint Louis, Missouri +1 locations
Conditions: Hepatitis C, Pregnancy Complications
Register for Updates
The HOPE Study: Characterizing Patients With Hepatitis B and C
NCT02995252
Recruiting
This is an observational, longitudinal, prospective study for sample collection and evaluation for future therapy or disease progression of chronic hepatitis B and C. Participants will be seen on an annual basis with optional additional visits for up to 10 years and provide samples for research and evaluation of disease progression. In addition, there is a longitudinal sub-study for treatment of hepatitis B that will involve 2 years of treatment with tenofovir alafenamide and blood collections w... Read More
Gender:
All
Ages:
Between 18 years and 99 years
Trial Updated:
04/02/2024
Locations: Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland +1 locations
Conditions: Hepatitis B， Chronic, Hepatitis C
Register for Updates
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
NCT06179498
Recruiting
The Partner Navigation Intervention Study is a randomized controlled study (RCT) to assess the efficacy and mechanism of action of the first behavioral intervention to increase hepatitis C (HCV) treatment initiation among adult people who inject drugs (PWID).
Gender:
All
Ages:
18 years and above
Trial Updated:
03/28/2024
Locations: University of California, San Francisco, San Francisco, California
Conditions: Hepatitis C
Register for Updates
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
NCT04162938
Recruiting
The investigators will conduct a randomized controlled clinical trial study in an urban emergency department in Baltimore to determine the impact of an educational app which is based on Leventhal's Common-Sense Model of Illness Representations framework, on HCV-infected ED patient's hepatitis C virus (HCV) health belief and knowledge as well as the downstream outcomes of the HCV Continuum of Care (linkage to care rate, initiation of HCV antiviral treatment, and sustained virologic response). Fir... Read More
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
03/14/2024
Locations: Johns Hopkins University, Baltimore, Maryland
Conditions: Hepatitis C
Register for Updates
A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients
NCT04508907
Recruiting
This study is being done to determine the effectiveness of using a combination of two different drugs in preventing the transmission of HCV from a HCV positive donor to a HCV negative solid organ recipient.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/11/2024
Locations: Mayo Clinic in Arizona, Phoenix, Arizona
Conditions: Hepatitis C, Kidney Transplant; Complications, Heart Transplant Infection
Register for Updates
HCV Test and Treat Utilizing Simplified HCV Patient Education
NCT05582681
Recruiting
The study hypothesis is that the test and treat model utilizing video-based patient education will have higher rates of hepatitis C virus (HCV) treatment initiation and treatment completion.
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
03/06/2024
Locations: Phoenix House, Long Island City, New York +2 locations
Conditions: Hepatitis C
Register for Updates
Tele-Harm Reduction
NCT05208697
Recruiting
The purpose of this study is to test 2 different methods for offering medications that treat HIV, cure Hepatitis C Virus (HCV) (if applicable) and treat substance use disorder (if desired) to people who inject drugs.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/29/2024
Locations: Care Resource The SPOT, Fort Lauderdale, Florida +2 locations
Conditions: IV Drug Usage, HIV Infections, Hepatitis C
Register for Updates
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
NCT01280825
Recruiting
The purpose of this study is to collect DNA samples from patients undergoing routine care at the University of Chicago. These samples will be tested for differences in genes that may suggest greater risk of side effects or chance of increased benefit from certain medications. The results will be made available to the patient's treating physician and the researchers will track whether or not this information is used in routine health care.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/26/2024
Locations: University of Chicago Medical Center, Chicago, Illinois
Conditions: Patients Undergoing Routine Health Care, Heart Diseases, Inflammatory Bowel Diseases, Autoimmune Disease, Inflammatory Disease, Blood Coagulation Disorders, Hepatitis C, Non-Metastatic Neoplasm
Register for Updates
Hepatitis C Treatment in Probation and Parole Office
NCT05413785
Recruiting
This prospective cohort study compares aims to determine the efficacy and effectiveness of telemedicine-supported on-site linkage to care and treatment in a community probation and parole office (P&P office) setting and compare the results with a historic control with referral to care. Research participants will be followed in the P&P office when they report to their officer during regularly scheduled appointments. Participants will receive treatment without having to travel to a specialist's of... Read More
Gender:
All
Ages:
Between 18 years and 99 years
Trial Updated:
01/05/2024
Locations: University of Kentucky, Lexington, Kentucky
Conditions: Hepatitis C, HCV
Register for Updates
Rural New England Health Study (Phase 2)
NCT05466331
Recruiting
This study will integrate mobile hepatitis C virus (HCV) testing and treatment with expanded syringe access in order to improve uptake of HCV testing and treatment, and reduce syringe sharing behavior in rural northern New England. The intervention aims to reach rural opioid injectors with HCV and to fill service gaps identified around access to syringe services and HCV testing and treatment, while limiting the burden on local partners. If effective, this mobile model of HCV telehealth integrate... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
11/28/2023
Locations: Mobile Study Van, Keene, New Hampshire +2 locations
Conditions: Hepatitis C, Opioid Use Disorder, IV Drug Usage
Register for Updates
Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants
NCT04701437
Recruiting
The overarching goal of this study is to develop a peer-based care coordination intervention for individuals with HCV who were recently released from correctional settings to promote linkage to and retention in HCV care. The investigators will assess the existing barriers and facilitators of HCV treatment initiation, HCV treatment completion, and sustained virologic response among individuals recently released from a U.S. jail or prisons in a randomized control trial. This study will assess the... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/09/2023
Locations: Prisma Health-Upstate, Greenville, South Carolina
Conditions: Hepatitis C
Register for Updates